U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 3C10H19O2.La
Molecular Weight 652.6755
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Lanthanum(3+) decanoate

SMILES

[La+3].CCCCCCCCCC([O-])=O.CCCCCCCCCC([O-])=O.CCCCCCCCCC([O-])=O

InChI

InChIKey=DGUXUKYGEXDTOW-UHFFFAOYSA-K
InChI=1S/3C10H20O2.La/c3*1-2-3-4-5-6-7-8-9-10(11)12;/h3*2-9H2,1H3,(H,11,12);/q;;;+3/p-3

HIDE SMILES / InChI

Molecular Formula C10H19O2
Molecular Weight 171.2567
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula La
Molecular Weight 138.9055
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Lanthanum hydroxide (La(OH)3) is a rare novel earth compound which has so far been fabricated with various morphologies such as nanopowders, nanotubes, nanowires, nanorods and nanobelts from different methods like solvothermal, hydrothermal, sol-gel and template assisted routes. This compound has many attractive applications in gas-exhaust convectors, optical coatings, catalysts, superconductors, hydrogen storage materials and next generation of high dielectric constant gate dielectrics. It is a useful carrier precipitate for a number of ions. It was applied to the collection of traces of aluminum, bismuth, gold, iridium, iron, lead, thallium and titanium in silver metal. It is a predecessor Lanthanum oxide, which has a great interest as catalyst material.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
FOSRENOL

Approved Use

FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end stage renal disease (ESRD).

Launch Date

1.09866241E12
PubMed

PubMed

TitleDatePubMed
A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report.
2009 Oct
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 18:26:11 UTC 2023
Edited
by admin
on Sat Dec 16 18:26:11 UTC 2023
Record UNII
4E87G99XH9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Lanthanum(3+) decanoate
Common Name English
Decanoic acid, lanthanum(3+) salt (3:1)
Systematic Name English
Decanoic acid, lanthanum(3+) salt
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID70890915
Created by admin on Sat Dec 16 18:26:12 UTC 2023 , Edited by admin on Sat Dec 16 18:26:12 UTC 2023
PRIMARY
PUBCHEM
219036
Created by admin on Sat Dec 16 18:26:12 UTC 2023 , Edited by admin on Sat Dec 16 18:26:12 UTC 2023
PRIMARY
FDA UNII
4E87G99XH9
Created by admin on Sat Dec 16 18:26:12 UTC 2023 , Edited by admin on Sat Dec 16 18:26:12 UTC 2023
PRIMARY
CAS
62654-13-1
Created by admin on Sat Dec 16 18:26:12 UTC 2023 , Edited by admin on Sat Dec 16 18:26:12 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE